Alon Ben-Noon

Co-Founder and CEO of NeuroSense Therapeutics. Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm which worked and collaborated with many leading pharmaceutical R&D companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. The firm’s diligent employees were pioneers, who paved the way to more efficient and accurate work […]

Dr. Ferenc Tracik

Dr. Ferenc Tracik, our chief medical officer has twenty years of experience in general management, medical affairs, clinical development and commercialization in the biotech industry. Before joining the Company, he served as the Global Head Medical of Orphazyme A/S. From May 2017 until November 2020, Dr. Tracik served as VP Medical Europe, Canada and Partner […]

Or Eisenberg

CFO at NeuroSense Therapeutics. Mr. Eisenberg is a registered CPA with broad experience in all aspects of public companies in Israel and in the US.Prior to joining NeuroSense, he served in several financial management positions in the biotech industry, including CFO and acting CEO of Wize Pharma Inc.Prior to that, Or served as controller of […]

Dr. Niva Russek-Blum

Dr. Niva Russek- Blum has over 17 years of experience in neuroscience, specifically Parkinson’s disease and ALS. Niva established her lab in 2012, leading research as a Principle Investigator under the auspices of Ben Gurion University, focusing on neurological and immune perspectives of neurodegenerative diseases. She established a CRO, utilizing high throughput-screening infrastructure required for […]

Diana Shtossel

Ms. Diana Shtossel has over 15 years of vast knowledge and expertise in Regulatory Affairs and in all aspects of drug development throughout the product life cycle. Ms. Shtossel has a significantt experience in development and registration of Drugs, Biologic Products, Combination Products and Medical Devices in US, EU, Canada, Israel and Rest of the […]

Dr. Shiran Zimri

Dr. Zimri is head of the Scientific Program, leading the research and development programs for ALS, Parkinson’s disease, and Alzheimer’s disease. Shiran is a pre-clinical drug development expert, with over 12 years of experience studying neurodegenerative diseases utilizing multidisciplinary methods. Shiran has vast expertise in leading projects and collaborations. Her work was published in leading […]

Hagit Binder

Ms. Hagit Binder has over 13 years of experience in the drug development industry. Previously, Ms. Binder held VP projects and a marketing position at Nextar Chempharma solutions. She has led projects in various therapeutic areas for both local and global companies. In addition, she oversaw all projects, was accountable for deliverables and adherence to […]

Nedira Salzman-Frenkel

Mrs. Salzman-Frenkel has been in the biotech industry for 8 years. In her last role as CEO of her family’s pharmaceutical firm, her company raised $84M in US federal government funding and $30 M in contract research work. She has founded 5 companies in the last 7 years and licensed 2 technologies to a public […]

Dr. Sharon Cohen Vered

Dr. Cohen Vered leads the CMC development at NeuroSense Therapeutics. She has been a development and operations executive for over 25 years, and has experience leading drug development (CMC) teams in the pharmaceutical industry, both in large multinational corporations as well as in startup environments. Prior roles include VP CMC at NeuroDerm for 10 years, […]

Yael Barak

Yael has over 18 years of experience in quality management system (QMS) and pharmacovigilance (PV) throughout the product life cycle. In her previous positions, she held different roles in Teva’s PV organization, among them: GVP auditor, PV training manager, Operations manager and in the last 8 years she led the global PV compliance group of […]

Vered Sasson

Clinical trials associate at NeuroSense Therapeutics. Vered is a certified CRA, with over six years of experience in the clinical trial field and health sciences. In her previous positions, she was head of a study coordinators team at a leading diabetes medical center, conducting multiple nephrology, cardiology and diabetes studies (phases 2 & 3). Vered […]

Dr. Raneen Nicola

Dr. Nicola is a neuroscientist, who focused her research on neurocognitive and neurobiological aspects of memory, neurogenesis, and neuroinflammation. She co-authored several scientific publications in peer-reviewed journals throughout her doctoral studies. At NeuroSense, Dr. Nicola conducts pre-clinical studies and biomarker research, as well as supports the R&D department. Dr. Nicola received her Ph.D. in Neuroscience […]